Staphylococcus aureus is a major cause of both community-and healthcare-acquired pneumonias. Inducible costimulator (ICOS) is part of the CD28 family of proteins and is a target for immune checkpoint therapy. We found ICOS highly expressed on activated CD4 cells in response to S. aureus. In the absence of ICOS, mice had improved survival in a pneumonia model with the methicillin-resistant Staphylococcus aureus (MRSA) strain USA300 and significant reductions in bacterial burden in a nonlethal acute pneumonia model. Infected Icos -/-mice had major reductions in several proinflammatory cytokines, neutrophils, inflammatory monocytes, and eosinophils compared to infected wild-type mice, while there was improved expression of CD11c and macrophage receptor with collagenous structure on the surface of alveolar macrophages. Early during infection infected Icos -/-mice had increased numbers of alveolar macrophages and expression of several surface markers on alveolar macrophages and neutrophils. ICOS signaling also contributed to the pathogenesis of the airway pathogens Klebsiella pneumoniae, Pseudomonas aeruginosa, and Streptococcus pneumoniae, and neutralizing antibody to ICOS led to improved clearance of S. aureus from the airway. Our results indicate that ICOS plays a significant role in orchestrating the innate immune response to S. aureus and other airway pathogens, and could be a potential immunomodulatory target to attenuate S. aureus-related immunopathology.
Staphylococcus aureus is an important human pathogen that is the causative agent of several important infections, including pneumonia. Staphylococcus aureus can lead to both community-and hospital-acquired pneumonia as well as a complication following influenza infection [1] . Methicillin-resistant S. aureus (MRSA) strains are more likely to lead to morbidity and mortality, and the MRSA strain USA300 is no exception [2] [3] [4] . The acute immune response to S. aureus in the airway is orchestrated by several cell types (epithelial cells, alveolar macrophages, neutrophils) and innate immune receptors that recognized microbial ligands [5, 6] . The immune response to S. aureus in the airway is a brisk but strong proinflammatory response, with the mechanisms and pathways behind this response not fully elucidated.
T cells express several receptors; one receptor is the CD28 family member [7] , inducible costimulator (ICOS). ICOS, as its name implies, is an inducible receptor that is expressed on activated T cells as well as on resting memory T cells. It is a homodimeric protein with similar stimulatory potency to CD28 that binds to its ligand ICOSL (B7-H2, B7RP-1, B7h) typically expressed on antigen presenting and B cells [8] . Stimulation of ICOS leads to CD28 independent T-cell activation [9, 10] , with ICOS capable of interacting with PI3K [11, 12] . Consistent with a role for ICOS in cellular signaling, mutations in its ligand (ICOSL) in human monocyte-derived dendritic cells have reduced cytokine production in response to microbial Toll-like receptor (TLR) ligands [13] . Given its role in T-cell activation, it is being actively investigated for its utility in cancer as well as blocking its function for autoimmune disorders [14, 15] .
Staphylococcus aureus is known to activate T-cell signaling through a variety of mechanisms, most prominently through its production of superantigens, such as enterotoxins A and B and toxic shock syndrome toxin (TSST-1). We recently demonstrated that T cells contribute to the immunopathogenesis of MRSA pneumonia [16] . Mice deficient in Rag2 or Cd4 had significantly improved outcomes to infection with S. aureus and also displayed reductions in several proinflammatory cytokines. These observations are in agreement with our humanized mouse model of S. aureus infection whereby NOD scid gamma (NSG) mice that lack B and T cells also had better outcomes to infection compared with standard C57BL/6 mice [17] . Absence of the CD28 coreceptor also leads to improvements in outcome when intranasally challenging mice with MRSA.
Here we report that the CD28 family member ICOS plays an important part in the pathogenesis of S. aureus pneumonia. Mice lacking ICOS are able to clear the infection from the airways more efficiently and have significant reductions in cytokine production. Early in the infection, ICOS-deficient mice have improved numbers of alveolar macrophages and increased activation of neutrophils and macrophages. We show that the contribution of ICOS to the pathogenesis of respiratory infection extends beyond S. aureus to several important bacterial pathogens and that bacterial burden can be reduced through neutralizing antibody. These studies extend our knowledge on the role of T-cell signaling pathways in the innate immune response to S. aureus and provide a potential host signaling target to reduced lung damage in the context of acute MRSA pneumonia.
MATERIALS AND METHODS

Mice Studies
C57BL6/J and Icos -/-mice were from Jackson Laboratories. Mice were intranasally infected while under anesthesia. Cytokines were quantitated by multiplex (Eve Technologies). Lungs were fixed in 4% paraformaldehyde overnight to prepare paraffin blocks for hematoxylin and eosin (H&E)-stained slides. Cells from bronchoalveolar lavage fluid (BALF) and lung homogenate were stained for flow cytometry and run on an LSRII (BD Biosciences).
Statistical Analyses
Animal data was assumed to not follow a normal distribution, so a nonparametric Mann-Whitney test was used. Pathology data was assessed using a parametric Student t test. Mortality data was assessed using Fisher exact test. Statistics were performed with Prism software (GraphPad version 7, La Jolla, California).
Additional methods are available in the Supplementary Data.
RESULTS
ICOS Expression Is Increased on Activated CD4 T Cells in Response to
S. aureus
ICOS expression is increased upon activation of T cells [8] , and we sought to determine if ICOS expression is induced upon respiratory infection with S. aureus. Mice were intranasally infected with the epidemic MRSA strain USA300 and ICOS expression was analyzed on various immune cell populations ( Figure 1 ). There was a higher proportion of ICOS-positive cells in the CD45 + population compared with CD45 -cells in the lung ( Figure 1A ). When these CD45 cells were further characterized into CD3 + and CD3 -cells, it was apparent that T cells were the major expressers and that they did increase ICOS in response to S. aureus ( Figure 1A ). When the T cells were further defined by CD4 and CD8 expression and whether they were activated or not, we observed activated CD4 cells to be the highest expressers of ICOS ( Figure 1B) . In response to S. aureus infection, CD4 T cells increased ICOS expression from 4.7% of cells to 11.81% (P < .01; Figure 1B ). However, when activated (CD69 + ) CD4 T cells were analyzed, a >5-fold increase in ICOS expression was observed (4.72%-22.04%; P < .01; Figure 1B ). ICOS expression was not observed on nonactivated CD8 + cells. We also examined expression of the ligand for ICOS and observed it to be most highly expressed in Ly6C + monocytes (42% above control; P < .01) and CD103 + dendritic cells (117% above control; P < .01). These data indicate that CD4 cells are the primary ICOS-expressing cell in response to S. aureus.
ICOS Contributes to the Pathogenesis of S. aureus Pneumonia
To determine the significance of S. aureus-induced ICOS expression in the airway, we tested its role in pathogenesis by intranasally infecting wild-type (WT) and ICOS-deficient mice ( Figure 2 ). In our model of acute pneumonia, mice lacking ICOS displayed significantly improved outcomes to infection ( Figure 2 ). Icos -/-mice had an improved capacity to clear the infection, with bacterial loads in the airway (as measured in BALF) reduced by 65% (P < .01) compared with similarly infected WT mice (Figure 2A ), whereas bacteria in the lung were reduced by 92% (P < .01) compared with infected WT mice ( Figure 2B ). Consistent with their reduced bacterial counts, infected Icos -/-mice had improved body temperatures compared to infected WT mice (26.8°C vs 28.5°C; P < .05; Figure 1C ). Increasing the inoculum size, we examined the contribution of ICOS in survival after infection. After 7 days of infection, the median survival of WT mice was 33%, whereas Icos -/-mice had a 71% survival rate (P < .05; Figure 1D ). Examination of lung pathology sections also reflected the improved outcomes of ICOS knockout mice. In low magnification images of H&E sections of the entire lung lobe, increased consolidation is evident in infected WT lung tissue but not in Icos -/-infected lung tissue ( Figure 2E ). Higher magnification images of lung H&E sections show that, upon infection, WT mice exhibit significantly increased consolidation and reduced architecture of the airway and in the absence of ICOS, airway architecture is significantly improved with reduced amounts of consolidation ( Figure 2F ). This is also evident in the blind pathology scoring ( Figure 2G ). One mechanism by which leukocytes clear invading pathogens is via reactive oxygen species (ROS). We measured ROS in BALF and observed levels to be 50% higher in infected Icos -/-mice compared to similarly infected WT mice ( Figure 2H ). This work indicates that ICOS plays a significant part in host-derived pathogenesis in response to S. aureus in the airway.
Proinflammatory Cytokine Production Is Significantly Reduced in the Absence of ICOS
To understand the improved phenotype associated with loss of ICOS, we quantified the cytokine response to S. aureus in the airway. We observed that cytokine levels in BALF of S. aureus-infected Icos -/-mice were significantly less than similarly infected WT mice ( Figure 3A ). Levels of CXCL2 (macrophage inflammatory protein 2-alpha [MIP-2]), ) and 14 (Icos -/-). E and F, Hematoxylin and eosin-stained sections of paraformaldehyde-fixed lung tissue. Scale bar equals 1 mm (E) and 100 μm (F). G, Pathology scored on a scale of 1 (normal) to 5 (severe). n = 8. H, Reactive oxygen species (ROS) activity from BALF. Data are from at least 2 independent experiments. Each point represents a mouse. Lines display median. *P < .05; **P < .01; ****P < .0001.
interleukin (IL) 1β, and IL-6 were reduced by 90%, 82%, and 44% respectively (P < .001; Figure 3A ). CXCL1 (KC) was reduced by 80% (P < .05; Figure 3A ) and IL-17 was reduced by 79% (P < .0001; Figure 3A ). Significant reductions were also observed with tumor necrosis factor (TNF), CCL3, colony-stimulating factor (CSF) 1, CCL2, CCL11, leukemia inhibitory factor (LIF), CSF2, IL-12p70, IL-5, IL-7, IL-13, and IL-3 ( Figure 3A ). No differences were observed with CSF3, CCL4, CXCL10, IL-1α, VEGF, IL-9, IL-15, IL-10, CCL5, IL-2, and IL-12p40 (Supplementary Figure 1) . One cytokine analyzed was observed to be increased: CXCL9 (monokine induced by interferon gamma [MIG]) levels were 186% higher (P < .01; Figure 3B ) in Icos -/-compared with WT mice. Given the contribution of myeloid cells in the response to other pathogen-associated molecular patterns in regard to ICOS signaling [13] , we also examined the capacity of bone marrow-derived macrophages from WT and Icos -/-mice to signal in response to S. aureus. We observed 2 cytokines, IL-6 and CSF3, to be reduced-30% and 48% (P < .05), respectively-in Icos -/-compared to WT cells ( Figure 3C ). These data suggest that ICOS signaling contributes greatly to the inflammatory response to S. aureus.
Altered Immune Cell Recruitment to the Airway in ICOS-Deficient Mice
To further understand the immune response in ICOS-deficient mice, we analyzed the immune cells recruited into the airway after infection. Mice lacking ICOS had reduced immune cell recruitment to the airway ( Figure 4A ). Neutrophil numbers were 2.9-fold (P < .01; Figure 4A ) less in the BALF, inflammatory Icos -/-mice exhibit a decreased inflammatory response to Staphylococcus aureus respiratory infection. Wild-type (WT) and Icos -/-mice were intranasally infected with 4 × 10 7 colony-forming units of S. aureus USA300 for 24 hours. Bronchoalveolar lavage fluid was assessed for cytokine levels using multiplex technology. A, Cytokines with decreased levels in infected Icos -/-vs infected WT mice. B, Cytokines with increased levels in Icos -/-vs infected WT mice. Graphs display means with standard error. n = 3 for phosphate-buffered saline and 11 for S. aureus-infected samples. C, Cytokine production in WT and Icos -/-bone marrow-derived macrophages in response to S. aureus. A representative experiment is shown. *P < .05; **P < .01; ***P < .001; ****P < .0001. Abbreviations: CSF, colony stimulating factor; IL, interleukin; LIF, leukemia inhibitory factor; PBS, phosphate-buffered saline; TNF, tumor necrosis factor; WT, wild-type.
monocytes were reduced by 5.7-fold (P < .05; Figure 4A ), and eosinophils were reduced by 1.5-fold (P < .05; Figure 4A ). No differences in CD86 expression or cell counts in lung homogenate were observed (Supplementary Figure 2B and 2C) . Consistent with the reduction in neutrophil numbers we also saw a reduction in myeloperoxidase (MPO) activity. MPO levels were reduced by 43% in Icos -/-vs WT infected mice ( Figure 4B ). We also examined the intensity of staining, expression, of various markers on the cell surface and observed increased staining of CD11c and macrophage receptor with collagenous structure (MARCO) on alveolar macrophages from ICOS-deficient mice. The mean fluorescence of CD11c on alveolar macrophages was increased by 104% (P < .01; Figure 4C ), and the scavenger receptor MARCO was increased by 73% (P < .01; Figure 4C ).
ICOS-Deficient Mice Show Improved Immune Function During Early
Infection
As we had observed significant improvement in outcome at 24 hours in Icos -/-mice infected with S. aureus, we examined an earlier time point to better understand why these mice clear the infection better. As at 24 hours, we see significant reductions in bacterial clearance, the changes we see may be directly related to the reduced bacterial burden. At 4 hours after infection with S. aureus USA300, we did not observe any significant differences in bacterial clearance ( Figure 5A and 5B). However, we did observe that WT mice had lower body temperatures (mean, 27.1°C) compared with similarly infected Icos -/-mice (mean, 29.1°C; P < .01; Figure 5C ). Potentially related to their improved body temperate, cytokine analysis from BALF indicated a 36% decrease in IL-1β levels in infected Icos -/-mice. IL-1β is known to contribute to immunopathology in the airways [18] . We also saw a 39% increase in CXCL1/KC levels ( Figure 5D ) and 38% decrease in IL-5 ( Figure 5F ), whereas no change was observed in TNF ( Figure 5D ). Related to the increased levels of CXCL1, while we did not observe any differences in neutrophil numbers (data not shown), differences in neutrophil surface markers were apparent. The granulocyte marker Ly6G was elevated by 24% (P < .0001; Figure 5E ) on Icos -/-neutrophils that had infiltrated into the airway and the integrin, CD11b, had on average a 26% higher fluorescence intensity on Icos -/-neutrophils compared to WT mice (P < .01; Figure 5E ). Infected Icos -/-mice also had 2.8-fold higher numbers of alveolar macrophages in their airways (P < .01; Figure 5F ). This increase in alveolar macrophages was also accompanied by increased alveolar macrophage surface marker expression. Levels of MARCO (17.5%; P < .05), CD200R (39%; P < .01), SiglecF (31%; P < .05), and CD11c (35%; P < .05) were all significantly increased on the surface of alveolar macrophages in S. aureus-infected Icos -/-mice compared with infected WT mice ( Figure 5G ). We performed killing and intracellular killing assays to determine if these changes in markers were reflective of changes in function. While we did not observe a difference in neutrophil killing or intracellular bacteria within alveolar macrophages ( Figure 5G ), the number of extracellular bacteria left after exposure to alveolar macrophages was reduced in cells from Icos -/-compared to WT mice ( Figure 5G ). These data indicate that, early in the response to infection, the absence of ICOS signaling reduces potential immunopathology, a result of reduced IL-1β production. The absence of ICOS also facilitates an improved response to S. aureus with improved alveolar macrophage numbers and expression of surface markers on neutrophils and alveolar macrophages.
ICOS Signaling Contributes to the Pathogenesis of Other Respiratory
Pathogens
To determine if the phenotype observed with Icos -/-mice was specific to S. aureus or more general to other respiratory . Each dot represents a mouse with lines at median. Graphs display means with standard error. n = 3 for uninfected, 13 for WT S. aureus infected, and 16 for Icos -/-S. aureus-infected samples. H, Killing capacity of alveolar macrophages and neutrophils from WT and Icos -/-mice. n = 3.*P < .05; **P < .01; ****P < .0001. Abbreviations: BALF, bronchoalveolar lavage fluid; CFU, colony-forming units; IL, interleukin; KC, keratinocyte chemoattractant; MARCO, macrophage receptor with collagenous structure; PBS, phosphate-buffered saline; TNF, tumor necrosis factor; WT, wild type.
pathogens, we examined the ability of Icos -/-mice to clear several other important respiratory pathogens. Pseudomonas aeruginosa and Klebsiella pneumoniae, along with S. aureus, are all ESKAPE pathogens (ie, Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species). ESKAPE pathogens are the major cause of nosocomial infections and also represent those bacterial species that represent the greatest threat to existing treatments due to ever-increasing antimicrobial resistance [19, 20] . Streptococcus pneumoniae is a leading cause of community-acquired pneumonia and pneumonia as a complication of influenza infection [21, 22] . We observed that removal of ICOS led to significant improvements in bacterial clearance in all of the pathogens tested ( Figure 6 ). Pseudomonas aeruginosa-infected Icos -/-mice had 97.5% (P < .01) and 91.5% (P < .01) less bacteria in their BALF and lungs, respectively, compared with WT mice (Figure 6A ). There were 77.8% fewer (P < .01) K. pneumoniae in airways of Icos -/-compared with WT mice, with 93.3% less bacteria in lung homogenate ( Figure 6B) . A non-statistically significant decrease of 26.2% in BALF from S. pneumoniae-infected Icos -/-was observed, with a 40.1% (P < .05) decrease in lung tissue ( Figure 6C ). We further confirmed our original data with S. aureus by infecting mice treated with a neutralizing ICOS antibody or immunoglobulin G control. The bacterial burden in mice treated with the ICOS antibody was reduced by 57% in BALF (P < .05) and 44% in the lung homogenate (P < .05) (Figure 7 ). These data indicate that ICOS contributes to the clearance of multiple bacterial pathogens from the airway.
DISCUSSION
We investigated the role of ICOS in the context of acute S. aureus pneumonia and observed that it played a role in the pathogenesis of infection. The acute host response to S. aureus infection can be excessive and lead to decreased capacity to clear infection [5] . We observed this in the context of ICOS null mice whereby a reduced inflammatory response was observed along with improved bacterial clearance and lung architecture. Likewise, infection with S. aureus leads to brisk mortality that if avoided early leads to long-term survival, as we observed in mice lacking ICOS, which displayed a significant survival advantage over similarly infected WT mice. This improved phenotype was observed to extend to several other bacterial airway pathogens.
This study also agrees with our previous work that an absence of T cells also improves the outcome of mice to respiratory infection with S. aureus [16] . In that study, we observed that Rag2 -/-and Cd4 -/-mice had improved outcomes to S. aureus infection. Consistent with that study, we see a significant reduction in several proinflammatory cytokines. Two significantly reduced cytokines were IL-17 and IL-1β. IL-17 has been shown to be important in the clearance of S. aureus from the airway [23] . However, our data indicate that its levels can be significantly reduced without compromising its protective effects [18] . IL-1 signaling has been shown to be important in the context of influenza coinfection with S. aureus, while treatment with the IL-1 antagonist drug Anakinra improved outcomes in acute pneumonia with MRSA alone [24, 25] . IL-1β has been shown to contribute to airway inflammation, recruiting neutrophils and macrophages, mucus metaplasia, and airway fibrosis. Given that we observed IL-1β to be reduced early 4 hours after infection and at 24 hours after infection, it is likely this too played a role in the improved outcomes we observed in S. aureus-infected Icos -/-mice.
Much of the immunopathology associated with S. aureus infection can be attributed to neutrophil influx, their products, and the cytokine and chemokines associated with their recruitment and function [26] [27] [28] . The immune response is a delicate balance between necessary cell recruitment and an overexuberant response that causes excessive immunopathology. We observed in infected Icos -/-mice a decrease in neutrophil numbers 24 hours after infection, suggesting an ablated response that might have limited detrimental immunopathology, along with significant reductions in cytokine production. Consistent with reduced neutrophil numbers, we also observed decreased MPO activity, which has been linked to tissue damage [29] . Alternatively, the decreased neutrophil number may have been a direct byproduct of the reduced bacterial burden at this time point. Although we did not observe an alteration in neutrophil numbers early in the response to infection (at 4 hours), we did observe the neutrophils in infected Icos -/-mice to express increased levels of the surface markers Ly6G and Ly6C, indicating they may have improved function. This phenotype is likely a consequence of the altered cytokine milieu in the absence of ICOS, as we observed an increase in CXCL1/KC levels. We also noted significant differences in alveolar macrophage numbers and increased levels of ROS in ICOS-deficient mice, both likely contributors to the improved clearance of S. aureus. We have previously shown these cells to be important in the clearance of S. aureus [6] and they are integral in regulation of the immune response in the airway [30] . After 4 hours of infection, there were significantly greater numbers of alveolar macrophages in the ICOS-deficient mice. This increased number is likely to have an impact on bacterial clearance, given their function. Consistent with alveolar macrophages potentially mediating the clearance phenotype, we also observed their surface markers to be significantly increased both early (4 hours) in infection and at the conclusion of the experiment (at 24 hours).
The capacity of S. aureus to induce activation of ICOS is likely through presentation of bacterial proteins and lipoproteins. TLR2 is known to be expressed on T cells and specifically CD4 T cells [31] , which play a more substantial role in acute bacterial infections [32] than do CD8 T cells. ICOS is also known to effect different functions in different T-cell types [33, 34] . Bacterial proteins and lipoproteins are known to activate CD4 T cells [35] [36] [37] and, given our results showing an improvement in outcome to multiple respiratory pathogens, this is a likely scenario. The reduction in T-cell signaling in the absence of ICOS likely contributes to reduced immunopathology and the capacity of the mice to clear the various bacterial agents. Staphylococcus aureus is also known to produce superantigens that lead to cross-linking of antigen-presenting cells to T cells. We have shown previously that inactivation of the superantigens of S. aureus USA300 does not have a phenotype in the murine model of acute pneumonia [16] . Mouse models are not appropriate to study staphylococcal superantigens given their human host specificity [38] and if they were involved in our model, we would have likely seen a broader induction of ICOS expression in other T-cell subsets.
Our observation that inactivation of a positive T-cell signaling pathway, ICOS, could lead to reduced bacterial burden and proinflammatory cytokine production was confirmed through the use of a neutralizing antibody. Manipulation of T-cell signaling pathways is an area of intense research as well as in the clinic. Approaches to enhance T-cell activity through the suppression of the PD-1/PD-L1 and CTLA-4 negative pathways are being utilized in oncology, while efforts to reduce T-cell activation are a focus within the autoimmune and transplantation fields [14, 15] . Engagement of ICOS has proven effective along with CTLA-4 blockade in cancer immunotherapy [39] , while its suppression is being investigated in the context of systemic lupus erythematosus [15] . Our work here suggests that suppression in the context of acute S. aureus pneumonia may also hold some benefits. This potential therapeutic approach would apply only to acute use. ICOS is known to impact the function of B cells and germinal center formation [9, [40] [41] [42] , whereas ICOS ligand is also expressed on B cells [8] , lending to its importance in the adaptive immune response. In humans, some ICOS mutations have been associated with common variable immunodeficiency disorder, but display variability in their clinical presentation [43] [44] [45] [46] . Given these clinical effects and the contribution of inflammation to S. aureus infection [5] , neutralization of ICOS would be most appropriate for cases of acute infection to limit immunopathology.
We provide further evidence that limiting the initial T-cell response to S. aureus infection is beneficial in the acute setting of pneumonia. This initial innate response to S. aureus plays a significant role in the production of proinflammatory cytokines and the activation status of important immune cells in the airway. Approaches that limit this initial robust immune response may help ameliorate disease and could be used in concert with existing therapeutic strategies.
